Rapid and sustained reduction of serum growth hormone and insulin-like growth factor-1 in patients with acromegaly receiving lanreotide Autogel® therapy: a randomized, placebo-controlled, multicenter study with a 52 week open extension

Author: Melmed Shlomo   Cook David   Schopohl Jochen   Goth Miklos   Lam Karen   Marek Josef  

Publisher: Springer Publishing Company

ISSN: 1386-341X

Source: Pituitary, Vol.13, Iss.1, 2010-03, pp. : 18-28

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content